Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ASSEMBLY BIOSCIENCES, INC. Director's Dealing 2018

Jan 3, 2018

33081_dirs_2018-01-03_a8688da8-e4e4-4993-ada4-63f168269f47.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ASSEMBLY BIOSCIENCES, INC. (ASMB)
CIK: 0001426800
Period of Report: 2018-01-01

Reporting Person: Colonno Richard James (See Remarks)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-01-01 Common Stock A 25000 Acquired 25000 Direct

Footnotes

F1: Represents shares of common stock issuable under a performance-based Restricted Stock Unit (RSU) Award dated December 8, 2017 that was granted under Assembly Biosciences, Inc.'s Amended and Restated 2014 Stock Incentive Plan. On January 1, 2018, a performance-based vesting condition was achieved with respect to these shares of common stock, which remain subject to time-based vesting and will vest in full on August 1, 2018, assuming the Reporting Person's continuous service through August 1, 2018.